Groenhuysen Wilhelmus CM
CIK 0001264783 Name as filed on the most recent filing
Filed as Groenhuysen Wilhelmus CM (47)
184 transaction lines · from 47 filings · filed 2004-08-10 to 2024-03-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
184 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-03-04 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,217 disposed | 16.01 | 19,484.17 | Form 4, filing 0001562180-24-002248 | |
| 2024-03-01 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,107 disposed | 16.03 | 33,768.68 | Form 4, filing 0001562180-24-002248 | |
| 2024-02-28 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,303 disposed | 16.14 | 37,176.87 | Form 4, filing 0001562180-24-001980 | |
| 2023-09-01 |
NovoCure Ltd NVCR |
S, Open-market sale | 294 disposed | 21.82 | 6,414.26 | Form 4, filing 0001562180-23-006683 | |
| 2023-03-03 |
NovoCure Ltd NVCR |
S, Open-market sale | 20,415 disposed | 76.16 | 1,554,794.15 | Form 4, filing 0001562180-23-002579 | |
| 2023-03-03 |
NovoCure Ltd NVCR |
S, Open-market sale | 3,528 disposed | 76.16 | 268,690.36 | Form 4, filing 0001562180-23-002579 | |
| 2023-03-03 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,692 disposed | 76.16 | 128,861.70 | Form 4, filing 0001562180-23-002579 | |
| 2023-03-02 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,213 disposed | 75.28 | 91,312.09 | Form 4, filing 0001562180-23-002491 | |
| 2023-03-01 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,164 disposed | 76.36 | 165,248.23 | Form 4, filing 0001645113-23-000025 | |
| 2022-09-02 |
NovoCure Ltd NVCR |
S, Open-market sale | 296 disposed | 79.04 | 23,394.95 | Form 4, filing 0001645113-22-000076 | |
| 2022-03-08 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,923 disposed | 70.10 | 204,902.30 | Form 4, filing 0001645113-22-000027 | |
| 2022-03-04 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,569 disposed | 70.41 | 180,875.58 | Form 4, filing 0001645113-22-000015 | |
| 2022-03-03 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,301 disposed | 74.50 | 96,921.90 | Form 4, filing 0001645113-22-000015 | |
| 2021-09-02 |
NovoCure Ltd NVCR |
S, Open-market sale | 181 disposed | 138.23 | 25,019.99 | Form 4, filing 0001645113-21-000107 | |
| 2021-03-08 |
NovoCure Ltd NVCR |
S, Open-market sale | 3,004 disposed | 130.81 | 392,941.22 | Form 4, filing 0001645113-21-000043 | |
| 2021-03-04 |
NovoCure Ltd NVCR |
S, Open-market sale | 3,854 disposed | 137.55 | 530,133.12 | Form 4, filing 0001645113-21-000040 | |
| 2021-03-02 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,392 disposed | 152.05 | 363,710.78 | Form 4, filing 0001645113-21-000029 | |
| 2020-09-18 |
NovoCure Ltd NVCR |
S, Open-market sale | 3,536 disposed | 109.23 | 386,223.14 | Form 4, filing 0001645113-20-000140 | |
| 2020-09-18 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,513 disposed | 108.49 | 272,645.42 | Form 4, filing 0001645113-20-000140 | |
| 2020-09-18 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,813 disposed | 110.24 | 199,865.12 | Form 4, filing 0001645113-20-000140 | |
| 2020-09-18 |
NovoCure Ltd NVCR |
S, Open-market sale | 200 disposed | 110.88 | 22,177.00 | Form 4, filing 0001645113-20-000140 | |
| 2020-09-18 |
NovoCure Ltd NVCR |
S, Open-market sale | 200 disposed | 106.92 | 21,383.00 | Form 4, filing 0001645113-20-000140 | |
| 2020-09-17 |
NovoCure Ltd NVCR |
S, Open-market sale | 7,868 disposed | 108.79 | 855,959.72 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-17 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,232 disposed | 107.94 | 240,910.92 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-17 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,500 disposed | 109.80 | 164,707.50 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-17 |
NovoCure Ltd NVCR |
S, Open-market sale | 500 disposed | 106.68 | 53,341.00 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-17 |
NovoCure Ltd NVCR |
S, Open-market sale | 300 disposed | 105.28 | 31,584.60 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-17 |
NovoCure Ltd NVCR |
S, Open-market sale | 100 disposed | 110.52 | 11,052.00 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 5,123 disposed | 107.66 | 551,557.55 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 3,279 disposed | 107.65 | 352,977.79 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 3,077 disposed | 106.67 | 328,223.59 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,100 disposed | 106.55 | 223,752.90 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,000 disposed | 105.80 | 211,600.00 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,700 disposed | 108.71 | 184,805.30 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,000 disposed | 108.57 | 108,569.00 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 800 disposed | 105.62 | 84,492.80 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 633 disposed | 107.18 | 67,847.47 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 600 disposed | 109.54 | 65,724.60 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 600 disposed | 107.97 | 64,784.40 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 500 disposed | 106.05 | 53,026.00 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 400 disposed | 109.55 | 43,821.60 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-16 |
NovoCure Ltd NVCR |
S, Open-market sale | 200 disposed | 109.16 | 21,831.00 | Form 4, filing 0001645113-20-000139 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 13,368 disposed | 104.45 | 1,396,287.60 | Form 4, filing 0001645113-20-000136 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 10,166 disposed | 104.68 | 1,064,227.71 | Form 4, filing 0001645113-20-000136 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,334 disposed | 106.02 | 247,443.68 | Form 4, filing 0001645113-20-000136 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,203 disposed | 104.53 | 230,281.79 | Form 4, filing 0001645113-20-000136 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,200 disposed | 99.33 | 218,521.60 | Form 4, filing 0001645113-20-000136 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,197 disposed | 99.33 | 218,232.40 | Form 4, filing 0001645113-20-000136 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 2,193 disposed | 104.55 | 229,284.73 | Form 4, filing 0001645113-20-000136 | |
| 2020-09-15 |
NovoCure Ltd NVCR |
S, Open-market sale | 1,900 disposed | 98.50 | 187,142.40 | Form 4, filing 0001645113-20-000136 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 1
- Open-market sale 183
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. GROENHUYSEN WILHELMUS CM, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001264783
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6